Active ingredient : Imatinib Imatinib
GLEEVEC, generically known as Imatinib, is a targeted therapy medication primarily used to treat certain types of cancer, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). This innovative treatment works by inhibiting specific proteins that promote cancer cell growth, thereby helping to slow or stop the progression of the disease.
Couldn't load pickup availability
Free shipping and returns available on all orders!
We ship all US domestic orders within 5-10 business days
GLEEVEC, known generically as Imatinib, is a targeted therapy medication used primarily to treat certain types of cancer, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). It works by inhibiting specific proteins that promote cancer cell growth, effectively slowing or stopping the progression of the disease.
GLEEVEC is indicated for:
Imatinib specifically targets and inhibits the BCR-ABL tyrosine kinase, a protein produced by the Philadelphia chromosome abnormality found in CML. By blocking this enzyme, GLEEVEC disrupts the signaling pathways that promote cancer cell proliferation and survival.
GLEEVEC is typically administered orally, with the dosage determined based on the type of cancer being treated. It is important to follow the prescribed dosage and schedule provided by your healthcare provider.
Common side effects may include:
Serious side effects can occur and should be reported to a healthcare provider immediately.
Before starting GLEEVEC, inform your healthcare provider about any existing medical conditions, allergies, or medications you are currently taking. Regular monitoring and follow-up are essential during treatment to assess effectiveness and manage side effects.
GLEEVEC (Imatinib) is a vital medication in the management of specific cancers. Its targeted action helps improve patient outcomes and quality of life. Always consult with a healthcare professional for personalized medical advice and treatment plans.